Alan Kaganov

Who is Alan Kaganov?

Alan Kaganov has been a partner at USVP since 1996, specializing in health care and utilizing his 25 years of experience in the medical device industry. His focus is on early-stage investments in the areas of medical technology, novel drug-device combinations, drug delivery systems and biopharmaceuticals.

Alan earned a B.S. in Mechanical Engineering at Duke University's Pratt School of Engineering, where he won the Distinguished Alumnus Award in 2004. He also serves on its Board of Visitors. He has a Sc.D. in Biomedical Engineering from Columbia University, and an M.B.A. from New York University. He has 15 U.S. patents in his name.

Prior to USVP, Alan was Vice President of New Business Development at Boston Scientific. During his tenure, the company completed a record number of investments and business alliances and became a market leader in interventional cardiology, radiology and endoscopy. Before that, he was CEO of EP Technologies, turning it into the recognized leader in catheter-based electrophysiology, Vice President of Technology and Business Development at the Baxter Corporation, and Research Development Director of the Medical Device Division of Wyeth.

He currently serves on the boards of A-Med Systems, Aptus Endosystems, Atricure, Cryovascular, Sanarus Medical, St. Francis Medical and Timi3 Systems.